Ferring Pharmaceuticals Inc recalls STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL B…
- Recall date
- July 21, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1506-2020
- FDA classification
- Class I
- Brand / firm
- Ferring Pharmaceuticals Inc
- Sold / distributed
- Nationwide within the United States.
Why it was recalled
Superpotent Drug
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC 0053-6871-00
Get recall alerts
Free email alert whenever Ferring Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ferring Pharmaceuticals Inc